Laboratory Diagnosis of SARS-CoV-2 Pneumonia.
Melissa R. Gitman,Maryia V. Shaban,Alberto Paniz-Mondolfi,Emilia Mia Sordillo +3 more
- Vol. 11, Iss: 7, pp 1270
TLDR
In this paper, the authors delineate the categories of testing measures developed to date, analyze the efficacy of collecting patient specimens from diverse regions of the respiratory tract, and present the up and coming technologies which have made pathogen identification easier and more accessible to the public.Abstract:
The emergence and rapid proliferation of Coronavirus Disease-2019, throughout the past year, has put an unprecedented strain on the global schema of health infrastructure and health economy. The time-sensitive agenda of identifying the virus in humans and delivering a vaccine to the public constituted an effort to flatten the statistical curve of viral spread as it grew exponentially. At the forefront of this effort was an exigency of developing rapid and accurate diagnostic strategies. These have emerged in various forms over the past year-each with strengths and weaknesses. To date, they fall into three categories: (1) those isolating and replicating viral RNA in patient samples from the respiratory tract (Nucleic Acid Amplification Tests; NAATs), (2) those detecting the presence of viral proteins (Rapid Antigen Tests; RATs) and serology-based exams identifying antibodies to the virus in whole blood and serum. The latter vary in their detection of immunoglobulins of known prevalence in early-stage and late-stage infection. With this review, we delineate the categories of testing measures developed to date, analyze the efficacy of collecting patient specimens from diverse regions of the respiratory tract, and present the up and coming technologies which have made pathogen identification easier and more accessible to the public.read more
Citations
More filters
Journal ArticleDOI
Probing the mutation independent interaction of DNA probes with SARS-CoV-2 variants through a combination of surface-enhanced Raman scattering and machine learning
TL;DR: In this article , a set of DNA probes targeting a specific segment of the nucleocapsid phosphoprotein (N) gene of SARS-CoV-2 with high binding efficiency was developed.
Journal ArticleDOI
A Novel Rapid Test to Detect Anti-SARS-CoV-2 N Protein IgG Based on Shear Horizontal Surface Acoustic Wave (SH-SAW)
Yu-Chi Peng,Chia-Hsuan Cheng,Hiromi Yatsuda,Szu-Heng Liu,Shih-Jen Liu,Takashi Kogai,Chen-Yen Kuo,Robert Wang +7 more
TL;DR: In this article, a shear-horizontal surface acoustic wave (SH-SAW) biosensor was developed to detect the anti-SARS-CoV-2 nucleocapsid antibody.
Journal ArticleDOI
Laboratory Diagnosis for SARS-CoV-2 Infection
TL;DR: The optimal diagnostic test for SARS-CoV-2 infection should be selected based on a patient's clinical syndrome and presentation in relation to symptom onset as mentioned in this paper , and the optimal test should be chosen based on the patient's symptoms and presentation.
Journal ArticleDOI
Comparative analysis of chest radiography and lung ultrasound to predict intra-hospital prognosis of patients admitted for acute SARS-CoV-2 pneumonia (COVID-19)
Jorge Rubio-Gracia,David Ibañez-Muñoz,Ignacio Giménez-López,Vanesa Garcés-Horna,Daniel López-Delgado,Jose Luis Sierra-Monzón,Silvia Crespo-Aznárez,Natacha Peña-Fresneda,Juan Ignacio Pérez-Calvo,Marta Sánchez-Marteles +9 more
TL;DR: In this paper , a comparison between the Schalekamp radiological lung scale and LUZ-score ultrasound scale was performed in stable COVID-19 patients, and the results showed that the LUZ scale failed to identify patients at higher risk at admission for the primary end-point.
Journal ArticleDOI
Peptide Binder with High-Affinity for the SARS-CoV-2 Spike Receptor-Binding Domain
TL;DR: The R1 peptide exhibited high-affinity for specific binding with the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein with a dissociation constant KD of (7.5 ± 1.9) × 10–10 M, which maintained high binding affinity with the RBD derived from Gamma, Lambda, Delta, and Omicron variants.
References
More filters
Journal ArticleDOI
Humoral Immune Response to SARS-CoV-2 in Iceland.
Daniel F. Gudbjartsson,Gudmundur L. Norddahl,Páll Melsted,Kristbjorg Gunnarsdottir,Hilma Holm,Elias Eythorsson,Asgeir O. Arnthorsson,Dadi Helgason,Kristbjorg Bjarnadottir,Ragnar Freyr Ingvarsson,Brynja Thorsteinsdottir,Steinunn Kristjánsdóttir,Kolbrun Birgisdottir,Anna M. Kristinsdottir,Martin I. Sigurdsson,Gudny A. Arnadottir,Erna V. Ivarsdottir,Margret B. Andresdottir,Frosti Jonsson,Arna B Agustsdottir,Jonas Berglund,Berglind Eiriksdottir,Run Fridriksdottir,Elisabet E Gardarsdottir,Magnus Gottfredsson,Olafia S Gretarsdottir,Steinunn Gudmundsdottir,Kjartan R Gudmundsson,Thora R Gunnarsdottir,Arnaldur Gylfason,Agnar Helgason,Brynjar O. Jensson,Aslaug Jonasdottir,Hakon Jonsson,Thordur Kristjansson,Karl G. Kristinsson,Droplaug N Magnusdottir,Olafur T. Magnusson,Lovisa Bjork Olafsdottir,Solvi Rognvaldsson,Louise le Roux,Gudrun Sigmundsdottir,Asgeir Sigurdsson,Gardar Sveinbjornsson,Kristin E Sveinsdottir,Maney Sveinsdottir,Emil A Thorarensen,Bjarni Thorbjornsson,Marianna Thordardottir,Jona Saemundsdottir,S Hjortur Kristjansson,Kamilla S Josefsdottir,Gisli Masson,Gudmundur Georgsson,Mar Kristjansson,Alma D. Möller,Runolfur Palsson,Thorolfur Gudnason,Unnur Thorsteinsdottir,Ingileif Jonsdottir,Patrick Sulem,Kari Stefansson +61 more
TL;DR: The authors' results indicate that antiviral antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis, and antiviral antibody titers assayed by two pan-Ig assays remained on a plateau for the remainder of the study.
Journal ArticleDOI
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2.
Anne L. Wyllie,John Fournier,Arnau Casanovas-Massana,Melissa Campbell,Maria Tokuyama,Pavithra Vijayakumar,Joshua L. Warren,Bertie Geng,M. Catherine Muenker,Adam J. Moore,Chantal B.F. Vogels,Mary E. Petrone,Isabel M. Ott,Peiwen Lu,Arvind Venkataraman,Alice Lu-Culligan,Jonathan Klein,Rebecca Earnest,Michael Simonov,Rupak Datta,Ryan Handoko,Nida Naushad,Lorenzo R. Sewanan,Jordan Valdez,Elizabeth B. White,Sarah Lapidus,Chaney C. Kalinich,Xiaodong Jiang,Daniel J. Kim,Eriko Kudo,Melissa M. Linehan,Tianyang Mao,Miyu Moriyama,Ji Eun Oh,Annsea Park,Julio Silva,Eric Song,Takehiro Takahashi,Manabu Taura,Orr-El Weizman,Patrick Wong,Yexin Yang,Santos Bermejo,Camila D. Odio,Saad B. Omer,Charles S. Dela Cruz,Shelli F. Farhadian,Richard A. Martinello,Akiko Iwasaki,Nathan D. Grubaugh,Albert I. Ko +50 more
TL;DR: Investigators report that saliva specimens and nasopharyngeal swab specimens had similar sensitivity in the detection of SARS-CoV-2 Infection.
Journal ArticleDOI
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.
Indwiani Astuti,Ysrafil +1 more
TL;DR: This review provides a complete review related to structure, origin, and how the body responds to this virus infection and explains the possibility of an immune system over-reaction or cytokine storm.
Journal ArticleDOI
Assay Techniques and Test Development for COVID-19 Diagnosis
Linda J. Carter,Linda V. Garner,Jeffrey Smoot,Yingzhu Li,Qiongqiong Zhou,Catherine J. Saveson,Janet M. Sasso,Anne C. Gregg,Divya J. Soares,Tiffany R. Beskid,Susan R. Jervey,Cynthia Liu +11 more
TL;DR: An ongoing theme of the COVID-19 pandemic is the need for widespread availability of accurate and efficient diagnostic testing for detection of SARS-CoV-2 and antiviral antibodies in infected indiv...
Journal ArticleDOI
Laboratory diagnosis of emerging human coronavirus infections - the state of the art.
TL;DR: The current laboratory methods available for testing coronaviruses are reviewed by focusing on the coronavirus disease 2019 (COVID-19) outbreak going on in Wuhan, with a focus on the SARS-CoV-2 infections.